Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003380
Status:
TERMINATED
Last Update Posted:
2013-06-10
First Post:
1999-11-01
Brief Title:
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian Fallopian Tube or Peritoneal Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
GOG Foundation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cavity Cancer |
| Fallopian Tube Cancer |
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| recurrent ovarian epithelial cancer | View |
| ovarian undifferentiated adenocarcinoma | View |
| ovarian mixed epithelial carcinoma | View |
| ovarian serous cystadenocarcinoma | View |
| ovarian mucinous cystadenocarcinoma | View |
| ovarian endometrioid adenocarcinoma | View |
| ovarian clear cell cystadenocarcinoma | View |
| fallopian tube cancer | View |
| primary peritoneal cavity cancer | View |
| Brenner tumor | View |